INSPIRE MEDICAL SYSTEMS INC (INSP) Fundamental Analysis & Valuation

NYSE:INSP • US4577301090

Current stock price

56.14 USD
+2.73 (+5.11%)
At close:
56.14 USD
0 (0%)
After Hours:

This INSP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. INSP Profitability Analysis

1.1 Basic Checks

  • In the past year INSP was profitable.
  • INSP had a positive operating cash flow in the past year.
  • In multiple years INSP reported negative net income over the last 5 years.
  • Of the past 5 years INSP 4 years had a positive operating cash flow.
INSP Yearly Net Income VS EBIT VS OCF VS FCFINSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • INSP has a better Return On Assets (16.03%) than 94.65% of its industry peers.
  • With an excellent Return On Equity value of 18.62%, INSP belongs to the best of the industry, outperforming 91.98% of the companies in the same industry.
  • INSP's Return On Invested Capital of 5.75% is fine compared to the rest of the industry. INSP outperforms 77.01% of its industry peers.
Industry RankSector Rank
ROA 16.03%
ROE 18.62%
ROIC 5.75%
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
INSP Yearly ROA, ROE, ROICINSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • The Profit Margin of INSP (15.95%) is better than 91.98% of its industry peers.
  • INSP's Operating Margin of 5.59% is fine compared to the rest of the industry. INSP outperforms 71.66% of its industry peers.
  • INSP has a better Gross Margin (85.39%) than 93.58% of its industry peers.
  • In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
Industry RankSector Rank
OM 5.59%
PM (TTM) 15.95%
GM 85.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
INSP Yearly Profit, Operating, Gross MarginsINSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. INSP Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INSP is destroying value.
  • Compared to 1 year ago, INSP has less shares outstanding
  • The number of shares outstanding for INSP has been increased compared to 5 years ago.
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INSP Yearly Shares OutstandingINSP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
INSP Yearly Total Debt VS Total AssetsINSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 8.92 indicates that INSP is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 8.92, INSP belongs to the best of the industry, outperforming 86.63% of the companies in the same industry.
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.92
ROIC/WACC0.63
WACC9.06%
INSP Yearly LT Debt VS Equity VS FCFINSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 6.08 indicates that INSP has no problem at all paying its short term obligations.
  • The Current ratio of INSP (6.08) is better than 80.21% of its industry peers.
  • A Quick Ratio of 4.56 indicates that INSP has no problem at all paying its short term obligations.
  • The Quick ratio of INSP (4.56) is better than 77.01% of its industry peers.
Industry RankSector Rank
Current Ratio 6.08
Quick Ratio 4.56
INSP Yearly Current Assets VS Current LiabilitesINSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. INSP Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 45.09% over the past year.
  • The Revenue has grown by 13.60% in the past year. This is quite good.
  • The Revenue has been growing by 51.20% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%

3.2 Future

  • INSP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.64% yearly.
  • INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.47% yearly.
EPS Next Y-20.55%
EPS Next 2Y2.59%
EPS Next 3Y11.8%
EPS Next 5Y14.64%
Revenue Next Year6.34%
Revenue Next 2Y7.23%
Revenue Next 3Y8.22%
Revenue Next 5Y8.47%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

4

4. INSP Valuation Analysis

4.1 Price/Earnings Ratio

  • INSP is valuated rather expensively with a Price/Earnings ratio of 22.37.
  • Based on the Price/Earnings ratio, INSP is valued a bit cheaper than the industry average as 77.01% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.77. INSP is around the same levels.
  • With a Price/Forward Earnings ratio of 28.15, INSP can be considered very expensive at the moment.
  • INSP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 73.26% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.75, INSP is valued a bit more expensive.
Industry RankSector Rank
PE 22.37
Fwd PE 28.15
INSP Price Earnings VS Forward Price EarningsINSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 77.01% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of INSP indicates a rather cheap valuation: INSP is cheaper than 88.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.6
EV/EBITDA 15.81
INSP Per share dataINSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The decent profitability rating of INSP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.59%
EPS Next 3Y11.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INSP Dividend Analysis

5.1 Amount

  • No dividends for INSP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSP Fundamentals: All Metrics, Ratios and Statistics

INSPIRE MEDICAL SYSTEMS INC

NYSE:INSP (4/30/2026, 8:04:00 PM)

After market: 56.14 0 (0%)

56.14

+2.73 (+5.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth60.87
Earnings (Last)02-11
Earnings (Next)05-04
Inst Owners120.05%
Inst Owner Change0.44%
Ins Owners1.01%
Ins Owner Change2.32%
Market Cap1.62B
Revenue(TTM)911.98M
Net Income(TTM)145.42M
Analysts72
Price Target91.79 (63.5%)
Short Float %10.16%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)176.52%
Min EPS beat(2)81.33%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)151.77%
Min EPS beat(4)81.33%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)214.54%
EPS beat(12)12
Avg EPS beat(12)205.03%
EPS beat(16)16
Avg EPS beat(16)165.1%
Revenue beat(2)0
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-0.7%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)1.13%
Revenue beat(8)3
Avg Revenue beat(8)0.06%
Revenue beat(12)6
Avg Revenue beat(12)1.03%
Revenue beat(16)10
Avg Revenue beat(16)3.19%
PT rev (1m)-3.94%
PT rev (3m)-35.72%
EPS NQ rev (1m)4.21%
EPS NQ rev (3m)-375.18%
EPS NY rev (1m)0.99%
EPS NY rev (3m)12.8%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-6%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-3.99%
Valuation
Industry RankSector Rank
PE 22.37
Fwd PE 28.15
P/S 1.77
P/FCF 20.6
P/OCF 13.82
P/B 2.07
P/tB 2.07
EV/EBITDA 15.81
EPS(TTM)2.51
EY4.47%
EPS(NY)1.99
Fwd EY3.55%
FCF(TTM)2.72
FCFY4.85%
OCF(TTM)4.06
OCFY7.23%
SpS31.67
BVpS27.12
TBVpS27.12
PEG (NY)N/A
PEG (5Y)N/A
Graham Number39.1383 (-30.28%)
Profitability
Industry RankSector Rank
ROA 16.03%
ROE 18.62%
ROCE 6.28%
ROIC 5.75%
ROICexc 9.27%
ROICexgc 9.27%
OM 5.59%
PM (TTM) 15.95%
GM 85.39%
FCFM 8.61%
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
F-Score7
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 275.84%
Cap/Sales 4.22%
Interest Coverage 371.93
Cash Conversion 180.21%
Profit Quality 53.97%
Current Ratio 6.08
Quick Ratio 4.56
Altman-Z 8.92
F-Score7
WACC9.06%
ROIC/WACC0.63
Cap/Depr(3y)567.8%
Cap/Depr(5y)515.09%
Cap/Sales(3y)4.29%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
EPS Next Y-20.55%
EPS Next 2Y2.59%
EPS Next 3Y11.8%
EPS Next 5Y14.64%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
Revenue Next Year6.34%
Revenue Next 2Y7.23%
Revenue Next 3Y8.22%
Revenue Next 5Y8.47%
EBIT growth 1Y41.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year682.44%
EBIT Next 3Y112.89%
EBIT Next 5Y62.93%
FCF growth 1Y-13.88%
FCF growth 3Y216.73%
FCF growth 5YN/A
OCF growth 1Y-10.19%
OCF growth 3Y116.23%
OCF growth 5YN/A

INSPIRE MEDICAL SYSTEMS INC / INSP Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to INSP.


Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?

ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.


What is the profitability of INSP stock?

INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for INSP stock?

The Earnings per Share (EPS) of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to decline by -20.55% in the next year.